Cardiovascular and systemic microvascular-effects of anti-vascular endothelial growth factor therapy for cancer

Journal of the American College of Cardiology

Volumn 60, Issue 7, 2012, Pages 618-625

  Belcik, J Todd ^a   Qi, Yue ^a   Kaufmann, Beat A ^a   Xie, Aris ^a   Bullens, Sherry ^b   Morgan, Terry K ^c   Bagby, Susan P ^a   Kolumam, Ganesh ^b   Kowalski, Joe ^b   Oyer, Jon A ^a   Bunting, Stuart ^b   Lindner, Jonathan R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GENENTECH INC   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

contrast echocardiography; VEGF; ventricular hypertrophy

Indexed keywords

ANGIOTENSIN II; G6 31; RAMIPRIL; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BLOOD VOLUME; CARDIOVASCULAR EFFECT; COMPLIANCE (PHYSICAL); CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HEART AFTERLOAD; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE PRESSURE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HEMODYNAMICS; HYPERTENSION; KIDNEY BLOOD FLOW; MALIGNANT NEOPLASTIC DISEASE; MICROANGIOPATHY; MOUSE; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG MODULUS;

ANIMALS; ANTIBODIES, MONOCLONAL; AORTA; ECHOCARDIOGRAPHY; HEMODYNAMICS; HYPERTENSION; KIDNEY; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOPLASMS; RAMIPRIL; RENAL CIRCULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864697674     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.053     Document Type: Article

References (25)

1. D.G. Duda, T.T. Batchelor, C.G. Willett, R.K. Jain VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects Trends Mol Med 13 2007 223 230
2. T. Kamba, D.M. McDonald Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 2007 1788 1795
3. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
4. S.S. Shord, L.R. Bressler, L.A. Tierney, S. Cuellar, A. George Understanding and managing the possible adverse effects associated with bevacizumab Am J Health Syst Pharm 66 2009 999 1013
5. R.J. Motzer, B.I. Rini, R.M. Bukowski Sunitinib in patients with metastatic renal cell carcinoma JAMA 295 2006 2516 2524
6. T. Kamba, B.Y. Tam, H. Hashizume VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature Am J Physiol Heart Circ Physiol 290 2006 H560 H576
7. T. Inai, M. Mancuso, H. Hashizume Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts Am J Pathol 165 2004 35 52
8. K. Tang, E.C. Breen, H.P. Gerber, N.M. Ferrara, P.D. Wagner Capillary regression in vascular endothelial growth factor-deficient skeletal muscle Physiol Genomics 18 2004 63 69
9. N. Steeghs, T.J. Rabelink, J. op 't Roodt Reversibility of capillary density after discontinuation of bevacizumab treatment Ann Oncol 21 2010 1100 1105
10. J.R. Horowitz, A. Rivard, R. van der Zee Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension Evidence for a maintenance role in quiescent adult endothelium Arterioscler Thromb Vasc Biol 17 1997 2793 2800
11. C.S. Facemire, A.B. Nixon, R. Griffiths, H. Hurwitz, T.M. Coffman Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression Hypertension 54 2009 652 658
12. M.H. Kappers, J.H. van Esch, W. Sluiter, S. Sleijfer, A.H. Danser, A.H. van den Meiracker Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels Hypertension 56 2010 675 681
13. V. Eremina, M. Sood, J. Haigh Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases J Clin Invest 111 2003 707 716
14. V. Eremina, J.A. Jefferson, J. Kowalewska VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136
15. D. Dawson, M.A. Vincent, E.J. Barrett Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound Am J Physiol Endocrinol Metab 282 2002 E714 E720
16. D.E. Le, J.P. Bin, M.P. Coggins, K. Wei, J.R. Lindner, S. Kaul Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography J Am Soc Echocardiogr 15 2002 857 863
17. R.P. Kelly, C.T. Ting, T.M. Yang Effective arterial elastance as index of arterial vascular load in humans Circulation 86 1992 513 521
18. C.Z. Behm, B.A. Kaufmann, C. Carr Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis Circulation 117 2008 2902 2911
19. K. Wei, A.R. Jayaweera, S. Firoozan, A. Linka, D.M. Skyba, S. Kaul Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion Circulation 97 1998 473 483
20. W.C. Liang, X. Wu, F.V. Peale Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF J Biol Chem 281 2006 951 961
21. G. Glick, E.H. Sonnenblick, E. Braunwald Myocardial force-velocity relations studied in intact unanesthetized man J Clin Invest 44 1965 978 988
22. C.R. Honig, C.L. Odoroff, J.L. Frierson Capillary recruitment in exercise: rate, extent, uniformity, and relation to blood flow Am J Physiol 238 1980 H31 H42
23. A. Patzak, A.E. Persson Angiotensin II-nitric oxide interaction in the kidney Curr Opin Nephrol Hypertens 16 2007 46 51
24. A. Hara, T. Wada, K. Furuichi Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis Kidney Int 69 2006 1986 1995
25. I. Shiojima, K. Sato, Y. Izumiya Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure J Clin Invest 115 2005 2108 2118